THE IMPACT OF A DRUG UTILIZATION REVIEW PROGRAM AS A CHANGE AGENT ON PHYSICIAN  PRESCRIBING BEHAVIOR FOLLOWING THE PUBLICATION OF A RANDOMIZED CLINICAL TRIAL

                         BJORNSON, DARREL CURTIS; PHD

                         UNIVERSITY OF MINNESOTA, 1987
 
                         HEALTH SCIENCES, PHARMACY (0572)
 

                         Literature shows that physicians' prescribing behavior is often discordant with randomized clinical trial
                         (RCT) results. Part of the problem may be due to a failure in the diffusion of innovation. This experimental
                         study tested the impact of the Minnesota Department of Human Services Drug Utilization Review (DUR)
                         Program as a change agent on physician adoption of a selected RCT (N Engl J Med 1986;314:1547-52).
                         An experimental group of Minnesota Medicaid physicians (n = 288) was sent a packet three months after
                         the RCT was published. The packet consisted of a letter from the DUR Coordinator, the journal article
                         reprint, and a drug history profile of a patient who might benefit from the information. A control group (n =
                         288) received no intervention. Descriptive analysis showed that two-thirds of the physicians were
                         previously aware of the RCT. Over one-half of them indicated awareness from the medical journal. Almost
                         all of the Internists and less than two-thirds of the Family Practitioners were previously aware. The majority
                         of the patients were being treated by Family Practitioners. Factors significantly associated with the
                         physician's intent to adopt related to their training, experience, peer comments, new drug availability, and
                         the size of the mortality reduction of the study drugs. Only the latter factor was associated with the RCT
                         itself. It was hypothesized that those physicians receiving a change agent intervention would be more
                         innovative (i.e. earlier in adopting) than those not receiving an intervention. At the end of four months,
                         the hypothesis was tested using nonparametric 'survival' analysis techniques which compared two
                         time-to-event (prescription change) distributions. The data did not support the hypothesis. The message
                         may have been more important than the change agent in the DUR Program's lack of effectiveness.
                         Changing prescribing behavior following the publication of RCTs remains a problem in the diffusion of
                         innovation. The lack of effectiveness of the DUR Program in this setting should not be construed as an
                         overall lack of Program effectiveness, but rather as an invitation for further evaluation and research of the
                         Program in its more traditional environment.

 


Social Systems Simulation Group
P.O. Box 6904
San Diego, CA  92166-0904
Roland Werner, Principal
Phone/FAX  (619) 660-1603
 
Email: rwerner@sssgrp.com
Location: http://www.sssgrp.com    

Copyright © 1996-2004 Social Systems Simulation Group.
All rights reserved.
Copyright|Trademark|Privacy